Metropolis Healthcare

Metropolis Healthcare, India’s second-largest and the most respected pathology laboratory chain, announced the launch of three…

Sector stakeholders share perspectives on revised tax slabs and their implications

The new screening panel offers gender-specific diagnostics and hereditary risk assessment aimed at improving early cancer…

Under the agreement, Metropolis’ wholly owned subsidiary Metropolis Histoxpert Digital Services will acquire 100 per cent…

The MedEngage Scholarship Summit, hosted by Metropolis Foundation, provided financial aid and research grants to 353 medical…

Acquisition strengthens presence in western Uttar Pradesh and expands B2C operations

Despite challenges, diagnostics in tier 2 and 3 cities are growing through PPPs and technology adoption

This test detects 14 high-risk HPV types in a single tube and is a clinically validated, FDA-approved, and WHO-prequalified…

Expect demand for early and precise diagnostics to surge due to expansion of telemedicine infrastructure through broadband…

Strategic acquisition to strengthen advanced cancer diagnostics and expand market presence across northern and eastern India